Berenberg Bank upgraded shares of Arkema (OTCMKTS:ARKAY – Free Report) from a hold rating to a strong-buy rating in a report published on Thursday morning, Zacks.com reports.
Arkema Stock Performance
Shares of OTCMKTS:ARKAY traded up $0.31 during midday trading on Thursday, hitting $87.73. The company had a trading volume of 7,840 shares, compared to its average volume of 4,273. Arkema has a 12-month low of $84.55 and a 12-month high of $114.15. The company has a fifty day moving average of $91.12 and a two-hundred day moving average of $93.97. The company has a market cap of $6.58 billion, a price-to-earnings ratio of 17.80, a PEG ratio of 0.42 and a beta of 1.27. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.86 and a quick ratio of 1.38.
Arkema (OTCMKTS:ARKAY – Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The basic materials company reported $2.98 EPS for the quarter. Arkema had a return on equity of 8.18% and a net margin of 3.80%. The firm had revenue of $2.73 billion for the quarter. On average, equities research analysts expect that Arkema will post 8.96 EPS for the current fiscal year.
Arkema Company Profile
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
See Also
- Five stocks we like better than Arkema
- Stock Splits, Do They Really Impact Investors?
- Battle of the Retailers: Who Comes Out on Top?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Stock Sentiment Analysis: How it Works
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.